What does interest and amortization expenses mean?

The total costs associated with servicing debt obligations and the systematic allocation of intangible asset costs over their useful lives. This metric captures the financial burden of the company's capital structure and non-cash accounting charges. It is a key indicator of the company's leverage and long-term investment in intangible assets.

King Pharmaceuticals KG Interest and amortization expenses

Interest and amortization expenses at other companies

OppFiOPFI

$8.51M-17.0%

Trinet GroupTNET

$13M-7.1%

Sachem Capital Corp.SACH

$6.06M-0.6%

BFS

Saul CentersBFS

$19.65M+17.3%

IngredionINGR

$9M0.0%

TecnoglassTGLS

$3.02M+127%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept kg:InterestAndAmortizationExpensesNet.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's interest and amortization expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's interest and amortization expenses?: King Pharmaceuticals (KG) reported interest and amortization expenses of $3.9M in Q1 2026.
What does interest and amortization expenses mean?: The total costs associated with servicing debt obligations and the systematic allocation of intangible asset costs over their useful lives. This metric captures the financial burden of the company's capital structure and non-cash accounting charges. It is a key indicator of the company's leverage and long-term investment in intangible assets.